HERPES ZOSTER

This study tests a new shingles vaccine called CRV-101 against the current vaccine, Shingrix, in adults aged 50 and older. The goal is to see if CRV-101 is as safe and triggers a similar immune response. About 1,500 participants will receive either the new vaccine or Shingrix and…

This study tests a new recombinant shingles vaccine in 960 healthy adults aged 40 and older. The goal is to check the vaccine's safety and how well it boosts the immune system against the shingles virus. Participants receive the vaccine and are monitored for side effects and immu…

This study tests a new shingles vaccine in 12,000 adults aged 40 and older to see how well it prevents shingles over 1 to 3 years after vaccination. Participants received two shots two months apart. The goal is to confirm the vaccine's long-term protection and safety.

This study tests whether injecting a numbing medicine and steroids into tender spots can reduce pain from shingles better than standard antiviral drugs alone. It involves 136 adults with severe shingles pain for less than 90 days. The main goal is to see if this approach lowers t…

This study looks at the safety of the shingles vaccine (HZ/su) in pregnant women aged 18-49 with weakened immune systems. Researchers will compare rates of major birth defects and other infant health problems between vaccinated and unvaccinated women. The goal is to gather real-w…